Literature DB >> 18610943

Determination of optimal rhodamine fluorophore for in vivo optical imaging.

Michelle R Longmire1, Mikako Ogawa, Yukihiro Hama, Nobuyuki Kosaka, Celeste A S Regino, Peter L Choyke, Hisataka Kobayashi.   

Abstract

Optical imaging has the potential to improve the efficacy of surgical and endoscopic approaches to cancer treatment; however, the optimal type of fluorescent probe has not yet been established. It is well-known that rhodamine-core-derived fluorophores offer a combination of desirable properties such as good photostability, high extinction coefficient, and high fluorescence quantum yield. However, despite the ubiquitous use of rhodamine fluorophores for in vivo optical imaging, it remains to be determined if unique chemical properties among individual rhodamine core family members affect fluorophore parameters critical to in vivo optical imaging applications. These parameters include preserved fluorescence intensity in low pH environments, similar to that of the endolysosome; efficient fluorescence signal despite conformational changes to targeting proteins as may occur in harsh subcellular environments; persistence of fluorescence after cellular internalization; and sufficient signal-to-background ratios to permit the identification of fluorophore-targeted tumors. In the present study, we conjugated 4 common rhodamine-core based fluorescent dyes to a clinically feasible and quickly internalizing D-galactose receptor targeting reagent, galactosamine serum albumin (GmSA), and conducted a series of in vitro and in vivo experiments using a metastatic ovarian cancer mouse model to determine if differences in optical imaging properties exist among rhodamine fluorophores and if so, which rhodamine core possesses optimal characteristics for in vivo imaging applications. Herein, we demonstrate that the rhodamine-fluorophore, TAMRA, is the most robust of the 4 common rhodamine fluorophores for in vivo optical imaging of ovarian cancer metastases to the peritoneum.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18610943      PMCID: PMC2756081          DOI: 10.1021/bc800140c

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  17 in total

Review 1.  Fluorescence imaging with near-infrared light: new technological advances that enable in vivo molecular imaging.

Authors:  Vasilis Ntziachristos; Christoph Bremer; Ralph Weissleder
Journal:  Eur Radiol       Date:  2002-07-19       Impact factor: 5.315

Review 2.  In vivo near-infrared fluorescence imaging.

Authors:  John V Frangioni
Journal:  Curr Opin Chem Biol       Date:  2003-10       Impact factor: 8.822

3.  Evolution of fluorescein as a platform for finely tunable fluorescence probes.

Authors:  Yasuteru Urano; Mako Kamiya; Kojiro Kanda; Tasuku Ueno; Kenzo Hirose; Tetsuo Nagano
Journal:  J Am Chem Soc       Date:  2005-04-06       Impact factor: 15.419

4.  Use of gene expression profiling to direct in vivo molecular imaging of lung cancer.

Authors:  Jan Grimm; David G Kirsch; Stephen D Windsor; Carla F Bender Kim; Philip M Santiago; Vasilis Ntziachristos; Tyler Jacks; Ralph Weissleder
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-23       Impact factor: 11.205

5.  Optical imaging of spontaneous breast tumors using protease sensing 'smart' optical probes.

Authors:  Christoph Bremer; Vasilis Ntziachristos; Benedikt Weitkamp; Gregor Theilmeier; Walter Heindel; Ralph Weissleder
Journal:  Invest Radiol       Date:  2005-06       Impact factor: 6.016

Review 6.  The multiple uses of fluorescent proteins to visualize cancer in vivo.

Authors:  Robert M Hoffman
Journal:  Nat Rev Cancer       Date:  2005-10       Impact factor: 60.716

7.  Noninvasive optical imaging of ovarian metastases using Cy5-labeled RAFT-c(-RGDfK-)4.

Authors:  Zhao-Hui Jin; Veronique Josserand; Jesus Razkin; Elisabeth Garanger; Didier Boturyn; Marie-Christine Favrot; Pascal Dumy; Jean-Luc Coll
Journal:  Mol Imaging       Date:  2006-07       Impact factor: 4.488

8.  A comparison of the emission efficiency of four common green fluorescence dyes after internalization into cancer cells.

Authors:  Yukihiro Hama; Yasuteru Urano; Yoshinori Koyama; Marcelino Bernardo; Peter L Choyke; Hisataka Kobayashi
Journal:  Bioconjug Chem       Date:  2006 Nov-Dec       Impact factor: 4.774

9.  Targeted optical fluorescence imaging of human ovarian adenocarcinoma using a galactosyl serum albumin-conjugated fluorophore.

Authors:  Andrew J Gunn; Yukihiro Hama; Yoshinori Koyama; Elise C Kohn; Peter L Choyke; Hisataka Kobayashi
Journal:  Cancer Sci       Date:  2007-09-02       Impact factor: 6.716

10.  Activatable fluorescent molecular imaging of peritoneal metastases following pretargeting with a biotinylated monoclonal antibody.

Authors:  Yukihiro Hama; Yasuteru Urano; Yoshinori Koyama; Peter L Choyke; Hisataka Kobayashi
Journal:  Cancer Res       Date:  2007-04-15       Impact factor: 12.701

View more
  20 in total

1.  Design, synthesis, and application of the trimethoprim-based chemical tag for live-cell imaging.

Authors:  Chaoran Jing; Virginia W Cornish
Journal:  Curr Protoc Chem Biol       Date:  2013

2.  Multimodality PET/MRI agents targeted to activated macrophages.

Authors:  Chuqiao Tu; Thomas S C Ng; Russell E Jacobs; Angelique Y Louie
Journal:  J Biol Inorg Chem       Date:  2013-10-29       Impact factor: 3.358

Review 3.  Fluorescent molecular imaging: technical progress and current preclinical and clinical applications in urogynecologic diseases.

Authors:  V M Alexander; P L Choyke; H Kobayashi
Journal:  Curr Mol Med       Date:  2013-12       Impact factor: 2.222

Review 4.  Insight into Fluorescence Imaging and Bioorthogonal Reactions in Biological Analysis.

Authors:  Yuexiang Ma; Qinhua Chen; Xiaoyan Pan; Jie Zhang
Journal:  Top Curr Chem (Cham)       Date:  2021-02-05

5.  The relative brightness of PEG lipid-conjugated polymer nanoparticles as fluid-phase markers in live cells.

Authors:  Lawrence P Fernando; Prakash K Kandel; P Christine Ackroyd; Kenneth A Christensen
Journal:  Anal Bioanal Chem       Date:  2012-09-30       Impact factor: 4.142

Review 6.  Molecular Imaging and Contrast Agent Database (MICAD): evolution and progress.

Authors:  Arvind Chopra; Liang Shan; W C Eckelman; Kam Leung; Martin Latterner; Stephen H Bryant; Anne Menkens
Journal:  Mol Imaging Biol       Date:  2012-02       Impact factor: 3.488

7.  High sensitivity detection of cancer in vivo using a dual-controlled activation fluorescent imaging probe based on H-dimer formation and pH activation.

Authors:  Mikako Ogawa; Nobuyuki Kosaka; Celeste A S Regino; Makoto Mitsunaga; Peter L Choyke; Hisataka Kobayashi
Journal:  Mol Biosyst       Date:  2010-02-09

Review 8.  New strategies for fluorescent probe design in medical diagnostic imaging.

Authors:  Hisataka Kobayashi; Mikako Ogawa; Raphael Alford; Peter L Choyke; Yasuteru Urano
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

9.  Fluorophore-quencher based activatable targeted optical probes for detecting in vivo cancer metastases.

Authors:  Mikako Ogawa; Nobuyuki Kosaka; Michelle R Longmire; Yasuteru Urano; Peter L Choyke; Hisataka Kobayashi
Journal:  Mol Pharm       Date:  2009 Mar-Apr       Impact factor: 4.939

10.  H-type dimer formation of fluorophores: a mechanism for activatable, in vivo optical molecular imaging.

Authors:  Mikako Ogawa; Nobuyuki Kosaka; Peter L Choyke; Hisataka Kobayashi
Journal:  ACS Chem Biol       Date:  2009-07-17       Impact factor: 5.100

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.